GlassScriptPhysician profile
Joseph R Leith
NPI 1598719890
$1,284.81
in general payments reported to CMS, 2019-2025
12 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2022: $20.30 · 2023: $26.79 · 2024: $889 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $710 · Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $709.77 |
| Food and Beverage | $361.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $992.90 | 2024-2025 | Mako, Triathlon |
| Assertio Therapeutics, INC. | $66.03 | 2019 | |
| Orthalign INC | $51.64 | 2024 | Orthalign Plus |
| Abbvie INC. | $26.79 | 2023 | |
| Horizon Therapeutics Plc | $25.53 | 2019 | |
| Bioventus LLC | $24.42 | 2019 | |
| Zimmer Biomet Holdings, INC. | $20.30 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.70 | 2019 | |
| Amgen INC. | $17.49 | 2019 | |
| Smith+Nephew, INC. | $17.23 | 2019 | |
| Zyla Life Sciences, INC. | $12.54 | 2019 | |
| Medtronic USA, INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Leith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.